Daniel I. Nathan, MD, is an Assistant Professor of Medicine (Hematology and Medical Oncology). He conducts clinical research on the relationship between clonal hematopoiesis and inflammation and sees patients at Mount Sinai-Union Square and The Ruttenberg Treatment Center with a focus on cytopenias and myeloid diseases.

Dr. Nathan earned his MD with Distinction in Research in Basic/Translational Science from Albert Einstein College of Medicine. He completed residency in Internal Medicine and fellowship in Hematology and Medical Oncology at Icahn School of Medicine at Mount Sinai, serving as Chief Fellow in his final year. He is the previous recipient of a T32 Training Award in Cancer Prevention and Control and a K12 Career Development Award to study mechanisms of inflammation in clonal hematopoiesis.